En randomiseret fase IIIb undersøgelse til sammenligning af virkning, tolerans og sikkerhed for anagrelid hydroklorid vs hydroxyurea hos højrisikopatienter med essentiel trombocytæmi.
A Phase IIIb, randomised study to compare the efficacy, tolerability and safety of anagrelide hydrochloride versus hydroxyurea in high-risk patients with essential thrombocythaemia.